Antiseizure Medications
Oxford University Press Inc (Verlag)
978-0-19-754121-0 (ISBN)
In the past decade, many new antiseizure medications (ASMs) have been introduced, so that there are now approximately 30 medications available to treat epilepsy. The healthcare provider therefore has many choices. However, having many alternatives also allows for the possibility of choosing an inappropriate or a suboptimal agent. The choice of medication should be guided by knowledge and familiarity with the ASMs.
In this new edition, the authors discuss choosing drugs when faced with various medical comorbidities; how to correctly prescribe, titrate, and taper drugs; how to monitor drug efficacy and side effects; how to diagnose and manage toxicity; interactions with other drugs; and other relevant issues. With updated references, terminology, materials, and drugs, this third edition meets the needs of clinicians who must treat their patients living with epilepsy.
Ali A. Asadi-Pooya, M.D. Professor of Epileptology Director, Epilepsy Research Center, Shiraz University of Medical Sciences Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University Michael R. Sperling, MD Baldwin Keyes Professor of Neurology Director, Jefferson Comprehensive Epilepsy Center Vice Chair for Research, Department of Neurology, Thomas Jefferson University
1. Diagnosis and Evaluation of Patients With Seizures
2. Antiseizure Medications Dosage Forms and Administration Guidelines
3. Mechanisms of Action and Pharmacokinetic Properties of Antiseizure Medications
4. Monitoring Antiseizure Medications and Their Toxicity
5. Choices of Antiseizure Medications Based on Specific Epilepsy Syndromes and Seizure Types
6. Clinically Important Drug Interactions With Antiseizure Medications
7. Aggravation of Seizures by Antiseizure Medications
8. Polytherapy With Antiseizure Medications
9. Antiseizure Medications in Pregnancy
10. Antiseizure Medications in Lactating Women
11. Antiseizure Medications in the Elderly
12. Antiseizure Medications in Patients With Renal Disease
13. Antiseizure Medications in Patients With Liver Disease
14. Antiseizure Medications and Metabolic Disorders
15. Antiseizure Medications in Patients With Hyperlipidemia
16. Antiseizure Medications in Patients With Diabetes Mellitus
17. Antiseizure Medications in Patients With Cardiovascular Disorders
18. Antiseizure Medications in Patients With Hematological Disorders
19. Antiseizure Medications in Patients on Chemotherapy or Immunosuppressive Therapy
20. Antiseizure Medications in Patients with Brain Tumors
21. Antiseizure Medications in Patients With Stroke
22. Antiseizure Medications in Patients With Multiple Sclerosis
23. Antiseizure Medications in Patients With Preexisting Psychiatric Problems
24. Antiseizure Medications and Cognition
25. Antiseizure Medications in Patients With Migraine Headaches
26. Antiseizure Medications in Patients With Neuropathic Pain Syndromes
27. Antiseizure Medications and Cutaneous Reactions
28. Antiseizure Medications and Ophthalmologic Problems
29. Antiseizure Medications and Weight Change
30. Antiseizure Medications and Bone Health
31. Antiseizure Medications in Patients With HIV Infection/AIDS
32. Antiseizure Medications in Patients With Coronavirus Infections
33. Antiseizure Medications in the Pipeline
| Erscheinungsdatum | 20.09.2022 |
|---|---|
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 203 x 126 mm |
| Gewicht | 404 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Schmerztherapie | |
| ISBN-10 | 0-19-754121-6 / 0197541216 |
| ISBN-13 | 978-0-19-754121-0 / 9780197541210 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
